Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Dr Faye Cooles.
Newcastle Authors
Title
Year
Full text
Alice Lin
Professor John Isaacs
Dr Faye Cooles
Role of IFN-α in Rheumatoid Arthritis
2024
Dr Wendy Funston
Dr Marie-Helene Ruchaud
Jonathan Scott
Jason Powell
Dr Faye Cooles
et al.
A human model of bilateral pulmonary vein sampling to assess the effects of one-lung ventilation on neutrophil function
2022
Dr Faye Cooles
Dr Jessica Tarn
Dr Dennis Lendrem
Najib Naamane
Alice Lin
et al.
Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming
2022
Alice Lin
Dr Faye Cooles
Professor John Isaacs
Precision medicine: the precision gap in rheumatic disease
2022
Professor John Isaacs
Sarah Brockbank
Dr Ayako Pedersen
Professor Catharien Hilkens
Dr Amy Anderson
et al.
RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients
2022
Dr Faye Cooles
Professor John Isaacs
The interferon gene signature as a clinically relevant biomarker in autoimmune rheumatic disease
2022
Jason Powell
Dr James Garnett
Dr Michael Mather
Dr Faye Cooles
Dr Bernard Verdon
et al.
Excess Mucin Impairs Subglottic Epithelial Host Defense in Mechanically Ventilated Patients
2018
Dr Faye Cooles
Dr Amy Anderson
Andrew Skelton
Dr Arthur Pratt
Professor Iain McInnes
et al.
Phenotypic and transcriptomic analysis of peripheral blood plasmacytoid and conventional dendritic cells in early drug naïve rheumatoid arthritis
2018
Dr Faye Cooles
Dr Amy Anderson
Dr Dennis Lendrem
Julie Norris
Dr Arthur Pratt
et al.
The interferon gene signature is increased in patients with early treatment-naive rheumatoid arthritis and predicts a poorer response to initial therapy
2017
Dr Faye Cooles
Dr Amy Anderson
Dr Rachel Harry
Julie Diboll
Lee Munro
et al.
Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapies
2016
Dr Faye Cooles
Dr Arthur Pratt
Dr Dennis Lendrem
Professor Fai Ng
Dr Terry Aspray
et al.
Retrospective analysis of the role of serum vitamin D in early rheumatic disease
2015
Dr Faye Cooles
Dr Amy Anderson
Professor Catharien Hilkens
Professor John Isaacs
The Interferon Gene Signature in Early Rheumatoid Arthritis Demonstrates No Significant Association with Disease Activity
2015
Dr Gary Reynolds
Dr Faye Cooles
Professor John Isaacs
Professor Catharien Hilkens
Emerging immunotherapies for rheumatoid arthritis
2014
Dr Faye Cooles
Dr Arthur Pratt
Dr Dennis Lendrem
Professor Fai Ng
Dr Terry Aspray
et al.
Retrospective analysis of the role of serum vitamin D in early rheumatic disease
2014
Dr Faye Cooles
Dr Arthur Pratt
Professor Fai Ng
Dr Terry Aspray
Professor John Isaacs
et al.
The Effect Of Vitamin D On Early Rheumatoid Arthritis: A Retrospective Cohort Analysis
2013
Dr Faye Cooles
Professor John Isaacs
Dr Amy Anderson
Treg Cells in Rheumatoid Arthritis: An Update
2013
Dr Faye Cooles
Professor Graham Jackson
Professor John Isaacs
Epstein-Barr virus-driven lymphoproliferative disorder post-CAMPATH-1H (alemtuzumab) in refractory polymyositis
2011
Jason Powell
Dr Faye Cooles
Professor Vinidh Paleri
Is undergraduate medical education working for ENT surgery? A survey of UK medical school graduates
2011
Dr Faye Cooles
Professor John Isaacs
Pathophysiology of rheumatoid arthritis
2011
Dr Faye Cooles
Dr Arthur Pratt
Dr Gillian Wilson
Professor John Isaacs
Professor Fai Ng
et al.
Prevalence and diagnostic outcome relating to vitamin D deficiency in new patients presenting to an early arthritis clinic over 12 months
2011
Dr Faye Cooles
Professor Graham Jackson
Professor John Isaacs
EBV driven lymphoproliferative disease following alemtuzumab (CAMPATH-1H) in refractory polymyositis
2010
Dr Faye Cooles
Professor John Isaacs
Treating to re-establish tolerance in inflammatory arthritis - lessons from other diseases
2010